Nisa Investment Advisors
TRML

Nisa Investment Advisors’s Tourmaline Bio TRML Stock Holding History

Nisa Investment Advisors’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,551
Closed -$74.2K – 3084
2025
Q3 		$74.2K Hold
1,551
– – ﹤0.01% 1518
2025
Q2 		$24.8K Sell
1,551
-31
-2% -$502 ﹤0.01% 1843
2025
Q1 		$24.1K Buy
1,582
+1,497
+1,761% +$24K ﹤0.01% 1808
2024
Q4 		$1.72K Buy
85
+18
+27% +$453 ﹤0.01% 2536
2024
Q3 		$1.72K Buy
+67
New +$1.12K ﹤0.01% 2433
2024
Q2 		– Sell
-7
Closed -$160 – 2973
2024
Q1 		$160 Hold
7
– – ﹤0.01% 2678
2023
Q4 		$183 Hold
7
– – ﹤0.01% 2570
2023
Q3 		$202 Hold
7
– – ﹤0.01% 2665
2023
Q2 		$219 Hold
7
– – ﹤0.01% 2695
2023
Q1 		$0 Buy
+7
New +$115 ﹤0.01% 2711

Nisa Investment Advisors's TRML Position: Q4 2025 in Review

Nisa Investment Advisors sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,551 shares — an estimated $74.2K sold.

Nisa Investment Advisors first reported a position in TRML in Q1 2023 and held it in 10 quarters. The position peaked at $74.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Nisa Investment Advisors reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,551 Tourmaline Bio shares in Q4 2025, an estimated $74.2K.
  • Nisa Investment Advisors first reported a position in Tourmaline Bio in Q1 2023 and held it in 10 quarters.
  • Nisa Investment Advisors's Tourmaline Bio position peaked at $74.2K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.